2 Materials and methods 2.1 Study design This study was a multi-center, prospective, double-blind, randomized clinical trial aimed to assess the absorption rate and hence bioavailibility of an innovative oral Sucrosomial B12 (Sidevit B12 developed by Pharmanutra S.p.A, Pisa, Italy) in enhancing circulatory B12 levels in healthy deficient adults, compared to various conventional oral B12 supplement formulations, selected randomly from local pharmacies at each participating center
Immunoadsorption to remove 2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME
Because of these limitations, a budget impact analysis of switching patients aged 18 years and older to oral supplements was conducted
What size implants should I get
Study 3: Heffernan 2000, oral administration Citation: Heffernan M., Jiang W.J., Thorburn A.W., Ng F.M